Portal de Periódicos da CAPES

A toxicity index for comparison of side effects among different drugs

1990; Wiley; Volume: 33; Issue: 1 Linguagem: Inglês

10.1002/art.1780330117

1529-0131

James F. Fries, Patricia W. Spitz, Catherine A. Williams, D. Blöch, Gurkirpal Singh, Helen B. Hubert,

Systemic Lupus Erythematosus Research

Arthritis & RheumatismVolume 33, Issue 1 p. 121-130 ArticleFree to Read A toxicity index for comparison of side effects among different drugs James F. Fries MD, Corresponding Author James F. Fries MD Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Stanford University Medical Center, HRP Building, Room 109C, Stanford, CA 94305Search for more papers by this authorPatricia W. Spitz Rn, Ms, Patricia W. Spitz Rn, Ms Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this authorCatherine A. Williams MA, Catherine A. Williams MA Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this authorDaniel A. Bloch PhD, Daniel A. Bloch PhD Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this authorGurkirpal Singh MD, Gurkirpal Singh MD Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this authorHelen B. Hubert Mph, Phd, Helen B. Hubert Mph, Phd Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this author James F. Fries MD, Corresponding Author James F. Fries MD Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Stanford University Medical Center, HRP Building, Room 109C, Stanford, CA 94305Search for more papers by this authorPatricia W. Spitz Rn, Ms, Patricia W. Spitz Rn, Ms Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this authorCatherine A. Williams MA, Catherine A. Williams MA Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this authorDaniel A. Bloch PhD, Daniel A. Bloch PhD Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this authorGurkirpal Singh MD, Gurkirpal Singh MD Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this authorHelen B. Hubert Mph, Phd, Helen B. Hubert Mph, Phd Division of Immunology and Rheumatology, Department of Medicien, Stanford University School of Medicine, Stanford, California.Search for more papers by this author First published: January 1990 https://doi.org/10.1002/art.1780330117Citations: 67AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 23: 137–145, 1980 2 Fries JF, Spitz PW, Mitchell DM, Roth SH, Wolfe F, Bloch DA: Impact of specific therapy upon rheumatoid arthritis. Arthritis Rheum 29: 620–627, 1986 3 Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF: The clinical value of the Stanford Health Assessment Questionnaire functional disability index in patients with rheumatoid arthritis. J Rheumatol 15: 1480–1488, 1988 4 Borg G, Allander E, Lund B, Berg E, Brodin U, Pettersson H, Trang L: Auranofin improves outcome in early rheumatoid arthritis: results from a 2-year, double blind, placebo controlled study. J Rheumatol 15: 1747–1754, 1988 5 Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA: Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology 96: 647–655, 1989 6 Fries JF, Spitz PW, Young DY: The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales. J Rheumatol 9: 789–793, 1982 7 Fries JF: Toward an understanding of patient outcome measurement. Arthritis Rheum 26: 697–704, 1983 8 Fries JF: The chronic disease data bank: first principles to future directions. J Philos Med 9: 161–180, 1984 9 Fries JF: The ARAMIS (American Rheumatism Association Medical Information System) post-marketing surveillance program. Drug Info J 19: 257–262, 1985 10 Fries JF: Alternatives in medical record formats. Med Care 12: 871–881, 1974 11 Pincus T, Callahan LF: Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis. J Chronic Dis 38: 973–984, 1985 12 Winer BJ: Statistical Principles in Experimental Design. New York, McGraw-Hill, 1971 13 Bloch DA, Segal MR: Empirical comparison of approaches to forming strata: using classification trees to adjust for covariates. J Am Stat Assoc (in press) 14 Fries JF, Bloch DA, Segal MR, Spitz PW, Williams CA, Lane NE: Postmarketing surveillance in rheumatology: analysis of purpura and upper abdominal pain. J Rheumatol 15: 348–355, 1988 15 Moses LE: Think and Explain with Statistics. Reading, MA, Addison-Wesley, 1986 16 Baum C, Kennedy DL, Forbes MB, Jones JK: Drug use in the United States in 1981. JAMA 251: 1293–1297, 1984 17 Coles LS, Fries JF, Kraines RG, Roth SH: From experiment to experience: side effects of non-steroidal anti-inflammatory drugs. Am J Med 74: 820–828, 1983 18 Faich GA, Dreis M, Tomita D: National adverse drug reaction surveillance 1986. Arch Intern Med 148: 785–787, 1988 19 Silman AJ, Petrie J, Hazleman B, Evans SJW: Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20-year follow-up study. Ann Rheum Dis 47: 988–992, 1988 20 Summons DPM: Neoplasia in rheumatoid arthritis. J Rheumatol 15: 1319–1322, 1988 Citing Literature Volume33, Issue1January 1990Pages 121-130 ReferencesRelatedInformation